student from 01.01.2022 until now
Vladivostok, Vladivostok, Russian Federation
employee from 01.01.2000 until now
Vladivostok, Vladivostok, Russian Federation
616-092
616.5
50
The article presents the significance of topical corticosteroids and topical calcineurin inhibitors in modern medicine, reveals the mechanisms of their action at the cellular and system level, pathogenetic aspects and associated side effects. This paper provides an analytical assessment of publication activity on both groups of drugs using Russian-language and foreign resources in the period from 2019 to 2024. A gradual increase in the number of publications mentioning topical calcineurin inhibitors and a slow decrease in the number of articles mentioning topical glucocorticoids are traced.
topical corticosteroids, topical calcineurin inhibitors, glucocorticosteroids, topical drugs, steroid-sensitive dermatoses, side effects, skin, structural changes
1. Rathi S.K., D'Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy // Indian Journal of Dermatology. -2012; -Vol. 57. -№ 4. -P. 251-259. https://doi.org/10.4103/0019-5154.97655
2. Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema // British Journal of Dermatology. -2000. -Vol. 142. -№ 5. -P. 931–936. https://doi.org/10.1046/j.1365-2133.2000.03473.x
3. Tan S.Y., Chandran N.S., Choi, E.CE. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal // Clinical Drug Investigation. -2021. -Vol. 41. -P. 835–842. https://doi.org/10.1007/s40261-021-01072-z EDN: https://elibrary.ru/CZNPCD
4. Siegfried E.C., Jaworski J.C., Hebert A.A. Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice // American Journal of Clinical Dermatology. -2013. -Vol. 14. -P. 163–178. https://doi.org/10.1007/s40257-013-0020-1 EDN: https://elibrary.ru/LVZZSF
5. Eichenfield, L.F. et al. Guidelines of care for the management of atopic dermatitis // Journal of the American Academy of Dermatology. -2014. -Vol. 71. - № 1. -P. 116 – 132. https://doi.org/10.1016/j.jaad.2014.03.023
6. Niculet E., Bobeica C., Tatu A. L. Glucocorticoid-Induced Skin Atrophy: The Old and the New // Clinical, Cosmetic and Investigational Dermatology. -2020, -Vol. 13. -P. 1041–1050. https://doi.org/10.2147/CCID.S224211 EDN: https://elibrary.ru/CLFFXR
7. Uva L., Miguel D., Pinheiro C., Antunes J., Cruz D., Ferreira J., Filipe P. Mechanisms of action of topical corticosteroids in psoriasis // International Journal of Endocrinology. -2012. https://doi.org/10.1155/2012/561018
8. Samcov A.V., Suharev A.V., Patrushev A.V. Lechenie atopicheskogo dermatita: preimuschestva takrolimusa pered topicheskimi kortikosteroidami [Elektronnyy resurs] // Effektivnaya farmakoterapiya. -2014. -№ 19. -S. 4–10. -URL: https://umedp.ru/upload/iblock/d92/d92ca4806a3d74318f02bdaf482fcaef.pdf EDN: https://elibrary.ru/SYTZCL
9. Breuer K., Werfel T., Kapp A. Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic Dermatitis // American Journal of Clinical Dermatology. -2005. -Vol. 6. -№ 2. -P. 65–77. https://doi.org/10.2165/00128071-200506020-00001 EDN: https://elibrary.ru/NWDMEB
10. Mehta A.B., Nadkarni N.J., Patil S.P., Godse K.V., Gautam M., Agarwal S. Topical corticosteroids in dermatology. Indian Journal of Dermatology Venereology and Leprology. -2016. -Vol. 82. -P. 371-378. https://doi.org/10.4103/0378-6323.178903
11. Stadnikova A.S., Novik G.A., Bagramova G.E., Vorob'eva A.S. Kompleksnaya terapiya hronicheskih allergodermatozov [Elektronnyy resurs] // Medicinskiy sovet. -2023. -Vol. 17. -№ 2. -S. 105-112. URL: https://cyberleninka.ru/article/n/kompleksnaya-terapiya-hronicheskih-allergodermatozov (data obrascheniya: 03.02.2025). DOI: https://doi.org/10.21518/ms2022-040; EDN: https://elibrary.ru/LHMGWJ
